These antibodies also recognize pathological tau inclusions upon immunohistochemical examination; NFTs and glial and globose NFT inclusions in AD and PSP, respectively, were recognized by these antibodies in regions of pathological interest. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.